Prosperity7 Ventures — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Cispolycispoly.comJan 2024

CisPoly develops non-invasive early cancer screening and diagnostic tests based on DNA methylation, targeting three major gynecological cancers: cervical, endometrial, and ovarian cancer.

BiotechDigital HealthFemTech

Co-investorsAramco Ventures

Nilenilesecure.com inFeb 2024

Nile provides an enterprise network-as-a-service platform that delivers wired and wireless connectivity for offices and campuses.

AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareSaaS

Co-investors8VC Geodesic Capital JC2 Ventures Koch Disruptive Technologies March Capital Partners Valor Equity Partners +4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.